Form 4 for LFST LifeStance Health Group, Inc.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001193125-26-102652 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-11 | 2026-03-09 | LFST | Bourdon David | CEO, Dir | F - Tax | $6.91 | -148.4K | 1.21M | -11% | -$1.03M |
| M | 2026-03-11 | 2026-03-09 | LFST | Bourdon David | CEO, Dir | A - Grant | $0.00 | +328.5K | 1.33M | +33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-09 | F | D | 86,024 | $6.91 | 1,398,247 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-09 | A | A | 205,550 | $0.00 | 1,484,271 | D | — | — | (F4) Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026. |
| 3 | Common | Common Stock | 2026-03-09 | F | D | 51,474 | $6.91 | 1,278,721 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-09 | F | D | 10,884 | $6.91 | 1,207,201 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-09 | A | A | 122,994 | $0.00 | 1,330,195 | D | — | — | (F2) Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026. |